Erenumab 是一种全人单克隆抗体。Erenumab 抑制降钙素基因相关肽 (CGRP) 受体。Erenumab 可用于预防发作性偏头痛。
| 生物活性 | Erenumab is a fully human monoclonal antibody. Erenumab inhibits thecalcitoningene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
